title: The effect of nutrition on the neural mechanisms potentially involved in melatonin-stimulated LH secretion in female Mediterranean goats.
abstract: This research examines which neural mechanisms among the endogenous opioid, dopaminergic, serotonergic and excitatory amino acid systems are involved in the stimulation of LH secretion by melatonin implantation and their modulation by nutritional level. Female goats were distributed to two experimental groups that received either 1.1 (group H; n=24) or 0.7 (group L; n=24) times their nutritional maintenance requirements. Half of each group was implanted with melatonin after a long-day period. Plasma LH concentrations were measured twice per week. The effects of i.v. injections of naloxone, pimozide, cyproheptadine and N-methyl-d,l-aspartate (NMDA) on LH secretion were assessed the day before melatonin implantation and again on days 30 and 45. The functioning of all but the dopaminergic systems was clearly modified by the level of nutrition, melatonin implantation and time elapsed since implantation. Thirty days after implantation, naloxone increased LH concentrations irrespective of the level of nutrition (P<0.05), similar to NMDA in the melatonin-implanted H goats (HM; P<0.01). On day 45, naloxone increased LH concentrations in the HM animals (P<0.05), similar to cyproheptadine in both the non-implanted H (HC) and the HM animals (P<0.01). Finally, at 45 days, NMDA increased the LH concentration in all subgroups (P<0.01). These results provide evidence that the effects of different neural systems on LH secretion are modified by nutritional level and melatonin implantation. Endogenous opioids seem to be most strongly involved in the inhibition of LH secretion on days 30 and 45 after melatonin implantation. However, the serotonergic mechanism appears to be most influenced by nutritional level.
authors: Department of Agroforestry Sciences, University of Huelva, Carretera de Palos de la Frontera s/n, Palos de la Frontera, 21819 Huelva, Spain. zarazaga@uhu.es
authors: Luis A
authors: LA
authors: Zarazaga
authors: Irma
authors: I
authors: Celi
authors: José Luis
authors: JL
authors: Guzmán
authors: Benoît
authors: B
authors: Malpaux
mesh_terms: D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D003533:Cyproheptadine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006041:Goats / Q000502:physiology*; D007986:Luteinizing Hormone / Q000378:metabolism*; D008550:Melatonin / Q000008:administration & dosage*; D016202:N-Methylaspartate / Q000008:administration & dosage / Q000494:pharmacology / Q000502:physiology; D009270:Naloxone / Q000494:pharmacology; D009490:Neurosecretory Systems / Q000187:drug effects / Q000502:physiology; D018847:Opioid Peptides / Q000502:physiology; D010868:Pimozide / Q000494:pharmacology; D012701:Serotonin / Q000502:physiology
chemical_list: D018847:Opioid Peptides; D010868:Pimozide; D003533:Cyproheptadine; D012701:Serotonin; D009270:Naloxone; D016202:N-Methylaspartate; D007986:Luteinizing Hormone; D008550:Melatonin; D004298:Dopamine